249 related articles for article (PubMed ID: 14985542)
21. Development of interleukin-1 receptor antagonist mutants with enhanced antagonistic activity in vitro and improved therapeutic efficacy in collagen-induced arthritis.
Dahlén E; Barchan K; Herrlander D; Höjman P; Karlsson M; Ljung L; Andersson M; Bäckman E; Hager AC; Walse B; Joosten L; van den Berg W
J Immunotoxicol; 2008 Apr; 5(2):189-99. PubMed ID: 18569390
[TBL] [Abstract][Full Text] [Related]
22. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
[TBL] [Abstract][Full Text] [Related]
23. Subtractive single-chain antibody (scFv) phage-display: tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules.
Eisenhardt SU; Schwarz M; Bassler N; Peter K
Nat Protoc; 2007; 2(12):3063-73. PubMed ID: 18079705
[TBL] [Abstract][Full Text] [Related]
24. Mapping of receptor binding sites on IL-1 beta by reconstruction of IL-1ra-like domains.
Boraschi D; Bossù P; Ruggiero P; Tagliabue A; Bertini R; Macchia G; Gasbarro C; Pellegrini L; Melillo G; Ulisse E; Visconti U; Bizzarri C; Del Grosso E; Mackay AR; Frascotti G; Frigerio F; Grifantini R; Grandi G
J Immunol; 1995 Nov; 155(10):4719-25. PubMed ID: 7594472
[TBL] [Abstract][Full Text] [Related]
25. Selection and characterization of anti-MUC-1 scFvs intended for targeted therapy.
Winthrop MD; DeNardo SJ; Albrecht H; Mirick GR; Kroger LA; Lamborn KR; Venclovas C; Colvin ME; Burke PA; DeNardo GL
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3845S-53S. PubMed ID: 14506182
[TBL] [Abstract][Full Text] [Related]
26. A novel human scFv fragment against TNF-alpha from de novo design method.
Chang H; Qin W; Li Y; Zhang J; Lin Z; Lv M; Sun Y; Feng J; Shen B
Mol Immunol; 2007 Jul; 44(15):3789-96. PubMed ID: 17485112
[TBL] [Abstract][Full Text] [Related]
27. [Preparation of human phage antibodies specific for SSA/Ro antigen and its sequence analysis].
Li YJ; Peng JM; Zhang FC
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1904-8. PubMed ID: 15631804
[TBL] [Abstract][Full Text] [Related]
28. Human single-chain Fv (scFv) antibody specific to human IL-6 with the inhibitory activity on IL-6-signaling.
Gejima R; Tanaka K; Nakashima T; Hashiguchi S; Ito Y; Yoshizaki K; Sugimura K
Hum Antibodies; 2002; 11(4):121-9. PubMed ID: 12775892
[TBL] [Abstract][Full Text] [Related]
29. Rapid isolation of intrabody candidates by using an optimized non-immune phage antibody library.
Nagano K; Imai S; Mukai Y; Nakagawa S; Abe Y; Kamada H; Tsunoda S; Tsutsumi Y
Pharmazie; 2009 Apr; 64(4):238-41. PubMed ID: 19435141
[TBL] [Abstract][Full Text] [Related]
30. A new yeast display vector permitting free scFv amino termini can augment ligand binding affinities.
Wang Z; Mathias A; Stavrou S; Neville DM
Protein Eng Des Sel; 2005 Jul; 18(7):337-43. PubMed ID: 15976011
[TBL] [Abstract][Full Text] [Related]
31. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains.
Staelens S; Desmet J; Ngo TH; Vauterin S; Pareyn I; Barbeaux P; Van Rompaey I; Stassen JM; Deckmyn H; Vanhoorelbeke K
Mol Immunol; 2006 Mar; 43(8):1243-57. PubMed ID: 16118019
[TBL] [Abstract][Full Text] [Related]
32. Production and characterization of an active single-chain variable fragment antibody recognizing CD25.
Muramatsu H; Yoshikawa K; Hayashi T; Takasu S; Kawada Y; Uchida K; Sato S; Takahashi T; Saga S; Ueda R
Cancer Lett; 2005 Jul; 225(2):225-36. PubMed ID: 15978327
[TBL] [Abstract][Full Text] [Related]
33. Anti-estradiol-17beta single-chain Fv fragments: Generation, characterization, gene randomization, and optimized phage display.
Kobayashi N; Kato Y; Oyama H; Taga S; Niwa T; Sun P; Ohtoyo M; Goto J
Steroids; 2008 Dec; 73(14):1485-99. PubMed ID: 18824188
[TBL] [Abstract][Full Text] [Related]
34. Direct demonstration of MuSK involvement in acetylcholine receptor clustering through identification of agonist ScFv.
Xie MH; Yuan J; Adams C; Gurney A
Nat Biotechnol; 1997 Aug; 15(8):768-71. PubMed ID: 9255792
[TBL] [Abstract][Full Text] [Related]
35. Cloning, expression, and identification of anti-carbofuran single chain Fv gene.
Wang H; Yang J; Liu X; Liang Y; Lei H; Shen Y; Xu X; Sun Y; Xu Z; He Y
Biotechnol Prog; 2009; 25(4):1018-24. PubMed ID: 19653307
[TBL] [Abstract][Full Text] [Related]
36. A single chain antibody obtained by cell panning of antibody phage inhibits homoaggregation of human leukemia cells.
Sui J; He Y; Jiang X; Dübel S; Han Z; Song Z
Hum Antibodies; 2004; 13(4):111-8. PubMed ID: 15671577
[TBL] [Abstract][Full Text] [Related]
37. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
[TBL] [Abstract][Full Text] [Related]
38. Antiidiotypic antibodies mimic molecular and functional properties of human IL-1 beta in vitro and in vivo.
Soprana E; Vigo E; Verani A; Blom J; Siccardi AG; Vercelli D; Viale G
Lymphokine Cytokine Res; 1994 Oct; 13(5):325-30. PubMed ID: 7858065
[TBL] [Abstract][Full Text] [Related]
39. Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions.
Finlay WJ; Cunningham O; Lambert MA; Darmanin-Sheehan A; Liu X; Fennell BJ; Mahon CM; Cummins E; Wade JM; O'Sullivan CM; Tan XY; Piche N; Pittman DD; Paulsen J; Tchistiakova L; Kodangattil S; Gill D; Hufton SE
J Mol Biol; 2009 May; 388(3):541-58. PubMed ID: 19285987
[TBL] [Abstract][Full Text] [Related]
40. Multivalent scFv display of phagemid repertoires for the selection of carbohydrate-specific antibodies and its application to the Thomsen-Friedenreich antigen.
Ravn P; Danielczyk A; Jensen KB; Kristensen P; Christensen PA; Larsen M; Karsten U; Goletz S
J Mol Biol; 2004 Oct; 343(4):985-96. PubMed ID: 15476815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
